Tag: Regeneron

All

EMA Accepts Otarmeni Gene Therapy for OTOF-Related Hearing Loss for Review

If approved, Regeneron's Otarmeni will be the first gene therapy for OTOF-related hearing loss in the European Union.

FDA Grants Accelerated Approval to Otarmeni Gene Therapy for OTOF-Related Hearing Loss
FDA Expediting Review of Regeneron Drug to Treat Genetic Hearing Loss
New DB-OTO Results Show Sustained Improvements for Children with Profound Genetic Hearing Loss
Regeneron’s Gene Therapy DB-OTO Trial Shows Promising Hearing Improvement
Regeneron’s Gene Therapy Improves Auditory Responses in Children with Genetic Hearing Loss
Regeneron Adds Hearing Loss Gene Therapy Program Via Decibel Therapeutics Acquisition

All

Regeneron to Acquire Decibel Therapeutics to Boost Hearing Loss Therapy Programs

Regeneron Pharmaceuticals and Decibel Therapeutics announced a definitive agreement for the acquisition of Decibel by Regeneron.

All

Sorry, No Posts Found

Sorry, No Posts Found